In this regard, we need to examine existing cohorts of children who years ago were truly infected (or were assumed to be infected) and were treated not within hours of detection of virus but within weeks to months to determine if such cases had similar outcomes to the Mississippi child and can shed light on the timing and intensity of starting therapy.
But the SRA makes clear that the scope and timing of the upgrade is currently being reviewed in the light of emerging information on costs and market requirements.